Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
While medical radiation produces many life-saving and life-sustaining therapies, it can also result in needless patient injuries, such as burns, hair loss and increased susceptibility to cancer. Such problems inevitably spur medical malpractice claims against physicians, and product liability claims against the manufacturers of radiology equipment.
As a barometer of the issue, one need only look to the Emergency Care Research Institute (ECRI) which, each year, releases a “top ten” list of health technology hazards. Its website offers a free download of a “Medical Technology Dangers Watch List.” At the end of 2010, ECRI ranked as the number one hazard the peril of overdose and dose errors during radiation therapy.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.